Methods and compositions related to thioesterase enzymes
View Patent ↗The present invention relates to novel mutant thioesterase enzymes and naturally-occurring equivalents thereof, compositions made from such enzymes and uses of thioesterase enzymes. In particular, the present invention provides mutant thioesterase enzymes that have altered properties, for example, altered substrate specificity, altered activity, altered selectivity, and/or altered proportional yields in the product mixtures. The present invention also provides polynucleotides encoding such mutant thioesterase enzymes, and vectors and host cells comprising such polynucleotides. The invention further provides for novel uses of thioesterases in the production of various fatty acid derivatives, which are useful as, or as components of, industrial chemicals and fuels.
1. A recombinant cell comprising an engineered thioesterase enzyme that converts a C10-, C12- or C14 fatty acyl substrate to a fatty acid, wherein the engineered thioesterase enzyme has an amino acid sequence that is at least about 90% identical to SEQ ID NO: 73 and has a substitution at an amino acid position selected from the group consisting of 14, 19, 43, 77, 78, 95, 108, 111, 132, and 145.
2. The recombinant cell of claim 1 , wherein the engineered thioesterase enzyme has one or more features selected from the group consisting of: (a) the amino acid residue at position 14 is alanine, cysteine, glutamic acid, phenylalanine, isoleucine, lysine, methionine, proline, glutamine, arginine, serine, threonine, or valine; (b) the amino acid residue at position 19 is cysteine or leucine; (c) the amino acid residue at position 43 is alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, glycine, histidine, leucine, methionine, asparagine, proline, arginine, threonine, valine or tryptophan; (d) the amino acid residue at position 77 is alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, glycine, histidine, lysine, leucine, asparagine, glutamine, serine, valine or tryptophan; (e) the amino acid residue at position 78 is alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, methionine, asparagine, proline, glutamine, arginine, serine, threonine, valine or tyrosine; (f) the amino acid residue at position 95 is phenylalanine, glycine, leucine, methionine, asparagine, glutamine, threonine or tryptophan; (g) the amino acid residue at position 108 is alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, glycine, histidine, isoleucine, leucine, methionine, arginine, serine, valine, tryptophan or tyrosine; (h) the amino acid residue at position 111 is cysteine, glutamic acid, leucine, methionine, proline, glutamine, arginine, valine, tryptophan or tyrosine; (i) the amino acid residue at position 132 is aspartic acid, glutamic acid, asparagine or threonine; (j) and the amino acid residue at position 145 is alanine, cysteine, aspartic acid, glutamic acid, glycine, isoleucine, leucine, methionine, asparagine, glutamine, threonine or tryptophan.
3. The recombinant cell of claim 1 , wherein said fatty acid is a C10-, C12- or C14 fatty acid.
4. The recombinant cell of claim 1 , wherein said engineered thioesterase enzyme is a TesA enzyme.
5. The recombinant cell of claim 4 , wherein said TesA enzyme is derived from a bacteria selected from the group consisting of Escherichia coli, Pectobacterium atrosepticum, Photobacterium profundum, Photorhabdus luminescens, Pseudomonas putida , and Vibrio harveyi.
6. The recombinant cell of claim 4 , wherein said TesA enzyme has a substitution at amino acid position 145.
7. The recombinant cell of claim 6 , wherein a tyrosine is replaced with a serine in said amino acid position 145.
8. The recombinant cell of claim 6 , wherein a tyrosine is replaced with a cysteine in said amino acid position 145 and an alanine is replaced with a tyrosine in amino acid position 111.
9. The recombinant cell of claim 6 , wherein a tyrosine is replaced with a cysteine in said amino acid position 145, a glycine is replaced with a methionine in amino acid position 78, and an arginine is replaced with a tryptophan in amino acid position 108.
10. The recombinant cell of claim 6 , wherein a tyrosine is replaced with a leucine in said amino acid position 145, a glycine is replaced with a methionine in amino acid position 78, and an arginine is replaced with a tryptophan in amino acid position 108.
11. The recombinant cell of claim 6 , wherein a tyrosine is replaced with a serine in said amino acid position 145, a glycine is replaced with a methionine in amino acid position 78, an arginine is replaced with a tryptophan in amino acid position 108, a valine is replaced with alanine in amino acid position 95, and a phenylalanine is replaced with a glutamic acid in amino acid position 132.
12. The recombinant cell of claim 1 , wherein said recombinant cell is a microbial cell.
13. The microbial cell of claim 12 , wherein said microbial cell is Escherichia coli.
14. The microbial cell of claim 12 , wherein said microbial cell is capable of spontaneously secreting or releasing said fatty acid.
15. A cell culture comprising the recombinant cell of claim 1 .